Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

NCT02331251 is registered in ClinicalTrials.gov with Western Regional Medical Center as lead sponsor.

NCT NCT02331251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02331251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
Lead sponsor
Western Regional Medical Center
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2014
Completion date
January 31, 2018
Enrollment
81 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, breast cancer, ovarian, pancreatic cancer, sarcoma, small cell lung cancer